Aggressive cancer tumors Abstract The neuroendocrine tumors NETs are more frequent during aggressive cancer tumors last decades. One of the major tools to evaluate this type of pathology is the neuroendocrine markers as chromogranin A, serotonin, urinary 5-hydroxy indolacetic acid, and neuron specific enolase.
Services on Demand
They change related to the disease progression, regardless therapy. Some of the drugs that are used for NETs as aggressive cancer tumors analogs for example octreotide might interfere with glucose metabolism. We analyzed in a retrospective study of 2 years the dynamic of the NET markers and the glycemia profile.
Material and Methods. All the patients had at least one assay per year.
Traducere "al tecilor" în engleză
The dose of octreotide varied from ovarian cancer treatment options to 50 mg, monthly. The fasting glucose insignificantly changed from baseline after 2 years.
No new case of diabetes was registered. One case of known diabetes needed insulin but interferon therapy was also added during this time period. The chromogranin A had sustained high values for all the 9 cases, marking the disease progression.
The neuron specific enolase significantly increased, and the serum serotonin as well as the 5HIIA was much higher in 2 cases with aggressive carcinoid symptoms. The NET markers and the glucose metabolism are most useful tools in the management of NETs, yet they are not correlated.
Neuroendocrine tumors. Endocr Relat Cancer. DOI: Oberndorfer S.
Я оставлю вас здесь на некоторое время и вернусь, когда вы почувствуете, что готовы.
Стоило им скрыться из виду, как она побежала по травянистому склону.
Karzinoide tumoren des dunndarms. Frank Z Pathol. Carcinoid Tumors.
al tecilor - Traducere în engleză - exemple în română | Reverso Context
Bellizzi AM. Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnosis immunohistochemistry.
Adv Anat Aggressive cancer tumors. Chromogranins A B C: widespread consitituents of secretory vesicles.
Ann N Y Acad Sci. Chromogranin A neuron specific enolase carcinoembryonic aggressive cancer tumors and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors.
- Brain biopsy revealed severe damage to the myelin sheath.
- MATERIALS AND METHODS: Imaging studies of 22 patients 12 men, mean age 60 years with histopathologically confirmed diagnosis, evaluated in the authors's institution during the last five years were retrospectively reviewed by two radiologists, with findings being consensually described focusing on changes observed at computed tomography.
- Papiloma renal pelvis
Да что там такое, скажи же .
Наконец-то хоть что-то его совершенно поразило.
Взгляни на эту мозаику, Элвин, - сказал Шут.
Regul Pept. The poor prognosis factors in G2 neuroendocrine tumor. Rom J Morphol Embryol.
The dedifferentiation of neuroendocrine tumor metastases: myth or reality? Octreotide for the treatment of hypoglycemia after insulin glargine overdose.
J Emerg Med. Biochemical testing for neuroendocrine tumors.
The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am ;40 1 Well-differentiated neuroendocrine tumor and osteoporosis: incidental finding?
Treatment of malignant midgut carcinoid tumours with a long-acting somatostatin analogue octreotide. Acta Oncol.
Long-term clinical outcome of somatostatin analogues for treatment of pregressive metastatic well-differentiated entero-pancreatic endocrine carcinoma. Ann Oncol. Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma.